Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. A. Ghebre, M. Bafadhel, D. Desai, R. May, A. Herath, P. Newbold, I. D. Pavord, C. Newby, P. R. Burton, C. E. Brightling (Leicester, Cambridge, United Kingdom). Clustering asthma and COPD provides new evidence for both “British” and “Dutch” hypotheses of COPD development. Eur Respir J 2013; 42: Suppl. 57, 4724

Member's Comments

No comment yet.

Related content which might interest you: GOLD and phenotypes: The new Czech COPD guidelines Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Are there any differences between Tunisian and European COPD phenotypes? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 What should be part of a comprehensive assessment of COPD? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 Defining asthma COPD overlap syndrome (ACOS): A population based study Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016 Implementation of COPD phenotypes in real life Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Evolution of COPD phenotypes in time - Czech multicentre research database of severe COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Distribution and outcomes of the new Spanish phenotype-based guideline for COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Heterogeneity of group D in the new GOLD classification of COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Gender differences in COPD patients Source: International Congress 2014 – Clinical presentations Year: 2014 Clinical and inflammatory characteristics of 'unreported' COPD exacerbations Source: Annual Congress 2013 –COPD mechanisms Year: 2013 COPD: GOLD 2011 and implications for clinical practice Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 What is the best biomarker of COPD stability? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Symptom profile of exacerbations in earlier and later COPD Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 Severity of airflow obstruction and multicomponent disease staging of COPD in the real-world primary care in Greece: The AEOLUS study Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients Source: International Congress 2016 – Monitoring airway diseases with different tools Year: 2016 The role of COPD in development of osteoporosis Source: International Congress 2014 – Markers Year: 2014 Night time dyspnea in COPD: A study of a general population Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 The influence of bronchial asthma as a comorbidity of COPD on the COPD assessment test (CAT) Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014